Quantitation of HLA-A∗0201 bound tumor associated antigens on a peptide pulsed B cell line

This publication has 30 references indexed in Scilit:

• Report of immune monitoring of prostate cancer patients undergoing T-cell therapy using dendritic cells pulsed with HLA-A2-specific peptides from prostate-specific membrane antigen (PSMA)
  The Prostate, 1998
• Follow-up evaluation of prostate cancer patients infused with autologous dendritic cells pulsed with PSMA peptides
  The Prostate, 1997
• A mutated beta-catenin gene encodes a melanoma-specific antigen recognized by tumor infiltrating lymphocytes.
  The Journal of Experimental Medicine, 1996
• An HLA-A2-restricted tyrosinase antigen on melanoma cells results from posttranslational modification and suggests a novel pathway for processing of membrane proteins.
  The Journal of Experimental Medicine, 1996
• A p16 ^INK4a -Insensitive CDK4 Mutant Targeted by Cytolytic T Lymphocytes in a Human Melanoma
  Science, 1995
• A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma.
  The Journal of Experimental Medicine, 1995
• BAGE: a new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes
  Immunity, 1995
• A peptide encoded by human gene MAGE‐3 and presented by HLA‐A2 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE‐3
  European Journal of Immunology, 1994
• Identification of wild‐type and mutant p53 peptides binding to HLA‐A2 assessed by a peptide loading‐deficient cell line assay and a novel major histocompatibility complex class I peptide binding assay
  European Journal of Immunology, 1994
• A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma
  Science, 1991